Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $3.42 in the prior trading day, Petmed Express, Inc (NASDAQ: PETS) closed at $3.55, up 3.80%. In other words, the price has increased by $3.80 from its previous closing price. On the day, 0.27 million shares were traded. PETS stock price reached its highest trading level at $3.639 during the session, while it also had its lowest trading level at $3.4.
Ratios:
Our goal is to gain a better understanding of PETS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.79 and its Current Ratio is at 1.05. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, Lake Street on May 25, 2023, initiated with a Buy rating and assigned the stock a target price of $20.
On January 20, 2022, Sidoti Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $32.
On November 18, 2021, Morgan Stanley started tracking the stock assigning a Underweight rating and target price of $25.Morgan Stanley initiated its Underweight rating on November 18, 2021, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 13 ’25 when Silvercape Investments Ltd bought 101,000 shares for $3.17 per share. The transaction valued at 320,170 led to the insider holds 2,579,696 shares of the business.
Silvercape Investments Ltd bought 118,200 shares of PETS for $379,422 on Aug 01 ’25. The 10% Owner now owns 2,478,696 shares after completing the transaction at $3.21 per share. On Jul 21 ’25, another insider, NINA CAPITAL HOLDINGS INC., who serves as the 10% Owner of the company, bought 25,000 shares for $3.50 each. As a result, the insider paid 87,425 and bolstered with 2,575,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PETS now has a Market Capitalization of 75861792 and an Enterprise Value of 40434300. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 1.73. Its current Enterprise Value per Revenue stands at 0.204 whereas that against EBITDA is -2.065.
Stock Price History:
The Beta on a monthly basis for PETS is 0.73, which has changed by -0.34980989 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, PETS has reached a high of $5.58, while it has fallen to a 52-week low of $1.57. The 50-Day Moving Average of the stock is 45.62%, while the 200-Day Moving Average is calculated to be 13.85%.
Shares Statistics:
The stock has traded on average 2.51M shares per day over the past 3-months and 15226990 shares per day over the last 10 days, according to various share statistics. A total of 21.02M shares are outstanding, with a floating share count of 15.13M. Insiders hold about 29.18% of the company’s shares, while institutions hold 33.27% stake in the company. Shares short for PETS as of 1764288000 were 1604421 with a Short Ratio of 1.07, compared to 1761868800 on 1663990. Therefore, it implies a Short% of Shares Outstanding of 1604421 and a Short% of Float of 10.609999.
Earnings Estimates
. The current rating of Petmed Express, Inc (PETS) reflects the combined expertise of 1.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.13 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.22 and -$0.22 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is $0.01, with 1.0 analysts recommending between $0.01 and $0.01.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for PETS’s current fiscal year. The highest revenue estimate was $199.06M, while the lowest revenue estimate was $199.06M, resulting in an average revenue estimate of $199.06M. In the same quarter a year ago, actual revenue was $226.97MBased on 1 analysts’ estimates, the company’s revenue will be $204.99M in the next fiscal year. The high estimate is $204.99M and the low estimate is $204.99M.
